Queen Mary University of London at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
Queen Mary University of London takes part in 8 sessions at FoG London 2027 in London, its home city. Its sessions centre on rare disease diagnosis and variant interpretation, including AI agents and proteomics for patients still undiagnosed after genome sequencing. Other topics include a human DNA methylation atlas, pharmacogenomics in healthcare, and spotting bias and data leakage in AI models.
| Organization | FoG London 2027 Attendance |
|---|---|
Queen Mary University of London London, UK | |
London research university with genomic medicine, computational biology, clinical pharmacology and population health research. | Talk Wed Jan 27 11:30–12:00 AI Agents for Rare Disease Diagnosis: Accelerating Variant Interpretation in Clinical Genomics How AI agents and large language models can speed up interpreting genetic variants for rare disease diagnosis within NHS genomic services. Talk Wed Jan 27 11:30–12:00 Pharmacogenomics in Healthcare How health systems could adopt pharmacogenomics, testing genes to guide prescribing, and whether to test in advance or only when needed. Talk Wed Jan 27 11:30–12:00 Proteomics to Identify Disease-Associated Variants in Patients with Rare Disease Undiagnosed After Genome Sequencing How unusually low blood protein levels could help diagnose rare disease patients left undiagnosed after whole-genome sequencing, and flag new disease genes. Talk Wed Jan 27 11:30–13:00 Interactive Session: Building Trust in AI – Identifying Bias, Data Leakage and Hidden Failure Modes AI in drug discovery & diagnostics Talk Wed Jan 27 15:30–16:00 Telomere Biology Disorders: Insights into Early-Life Programming and Lifelong Disease Risk How rare congenital disorders show why telomeres, the protective caps on chromosome ends, matter early in life and shape lifelong disease risk. Talk Thu Jan 28 14:10–14:40 From Genomic Risk to Precision Prevention: Transforming Women's Cancer Care How population genomic testing can find people at higher risk of women's cancers and guide targeted screening and prevention. Talk Thu Jan 28 15:10–15:40 A Human DNA Methylation Atlas for Epigenomic Interpretation How an atlas of DNA methylation marks across healthy human cell types helps interpret epigenetic data and cell-free DNA in blood. Talk Thu Jan 28 16:40–17:10 Rethinking Monogenic DIsease in the Era of Population Genomics How population-scale genome data and new ways to detect repeated DNA sequences are changing how single-gene diseases are understood. |
Find decision makers at Queen Mary University of London
Tell us what you sell and we’ll find the people at Queen Mary University of London most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction